Alpha Crest Capital Management LLC Abb Vie Inc. Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $731,847 - $839,380	-5,453 Reduced 20.16%	21,597 $2.9 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $2.44 Million - $3.1 Million	17,729 Added 190.2%	27,050 $4.14 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $1.41 Million - $1.75 Million	-10,716 Reduced 53.48%	9,321 $1.51 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $494,822 - $626,093	-4,606 Reduced 18.69%	20,037 $2.71 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $11.9 Million - $13.5 Million	-111,978 Reduced 81.96%	24,643 $2.66 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $9.74 Million - $10.8 Million	92,563 Added 210.09%	136,621 $15.4 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $3.33 Million - $3.67 Million	32,545 Added 282.68%	44,058 $4.77 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $5.51 Million - $7.44 Million	-68,450 Reduced 85.6%	11,513 $1.23 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $6.61 Million - $7.76 Million	76,951 Added 2554.81%	79,963 $7 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $1.99 Million - $2.66 Million	-27,116 Reduced 90.0%	3,012 $296,000
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $803,347 - $1.22 Million	12,455 Added 70.47%	30,128 $2.3 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $921,316 - $1.15 Million	12,773 Added 260.67%	17,673 $1.57 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $2.65 Million - $3.18 Million	-42,027 Reduced 89.56%	4,900 $371,000
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $2.22 Million - $2.84 Million	33,779 Added 256.91%	46,927 $3.41 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $1.01 Million - $1.19 Million	13,148 New	13,148 $1.06 Million

Others Institutions Holding ABBV

# of Institutions

4,138

Shares Held

1.29B

Call Options Held

17M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account